ID: ALA377169

Max Phase: Preclinical

Molecular Formula: C20H21ClN4O2

Molecular Weight: 384.87

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)c1c(NC(=O)Nc2ccccc2Cl)c(=O)n(-c2ccccc2)n1C

Standard InChI:  InChI=1S/C20H21ClN4O2/c1-13(2)18-17(23-20(27)22-16-12-8-7-11-15(16)21)19(26)25(24(18)3)14-9-5-4-6-10-14/h4-13H,1-3H3,(H2,22,23,27)

Standard InChI Key:  NYMNKQKVDUIVME-UHFFFAOYSA-N

Associated Targets(Human)

Lipoxin A4 receptor 3472 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 384.87Molecular Weight (Monoisotopic): 384.1353AlogP: 4.60#Rotatable Bonds: 4
Polar Surface Area: 68.06Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.52CX Basic pKa: CX LogP: 3.55CX LogD: 3.55
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: -1.62

References

1. Bürli RW, Xu H, Zou X, Muller K, Golden J, Frohn M, Adlam M, Plant MH, Wong M, McElvain M, Regal K, Viswanadhan VN, Tagari P, Hungate R..  (2006)  Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents.,  16  (14): [PMID:16697190] [10.1016/j.bmcl.2006.04.068]
2. Frohn M, Xu H, Zou X, Chang C, McElvaine M, Plant MH, Wong M, Tagari P, Hungate R, Bürli RW..  (2007)  New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation.,  17  (23): [PMID:17920884] [10.1016/j.bmcl.2007.09.043]

Source